FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

W Meyer

Research Profile

Chemicals & Drugs

Genes & Molecular Sequences

Genes, ras

Physiology

Drug Resistance, Neoplasm

Concepts & Ideas

Procedures

Disorders

Anatomy

Tumor Cells, Cultured

Living Beings

Moloney murine leukemia virus

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
John Nemunaitis; J Cox; S Hays; W Meyer; R Kebart; N Ognoskie; A Courtney; Y Yu; H Rasmussen; A Tong
Prognostic role of K-ras in patients with progressive colon cancer who received treatment with Marimastat (BB2516).
John Nemunaitis; T Fong; Francis J Burrows; J Bruce; George Peters; N Ognoskie; W Meyer; D Wynne; Ronald Kerr; John Pippen; F Oldham; D Ando
Phase I trial of interferon gamma retroviral vector administered intratumorally with multiple courses in patients with metastatic melanoma.
A Singh; A Tong; N Ognoskie; W Meyer; John Nemunaitis
Improved survival in patients with advanced colorectal carcinoma failing 5-fluorouracil who received irinotecan hydrochloride and have high intratumor C-fos expression.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of W Meyer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2000: John Nemunaitis; J Cox; S Hays; W Meyer; R Kebart; N Ognoskie; A Courtney; Y Yu; H Rasmussen; A Tong
Prognostic role of K-ras in patients with progressive colon cancer who received treatment with Marimastat (BB2516).
Cancer investigation 2000;18(3):185-90.
1999: John Nemunaitis; T Fong; Francis J Burrows; J Bruce; George Peters; N Ognoskie; W Meyer; D Wynne; Ronald Kerr; John Pippen; F Oldham; D Ando
Phase I trial of interferon gamma retroviral vector administered intratumorally with multiple courses in patients with metastatic melanoma.
Human gene therapy 1999;10(8):1289-98.
1998: A Singh; A Tong; N Ognoskie; W Meyer; John Nemunaitis
Improved survival in patients with advanced colorectal carcinoma failing 5-fluorouracil who received irinotecan hydrochloride and have high intratumor C-fos expression.
American journal of clinical oncology 1998;21(5):466-9.
1998: John Nemunaitis; C Bohart; T Fong; W Meyer; G Edelman; R S Paulson; Douglas Orr; V Jain; J O'Brien; Joseph Kuhn; K J Kowal; S Burkeholder; J Bruce; N Ognoskie; D Wynne; D Martineau; D Ando
Phase I trial of retroviral vector-mediated interferon (IFN)-gamma gene transfer into autologous tumor cells in patients with metastatic melanoma.
Cancer gene therapy 1998;5(5):292-300.
1998: John Nemunaitis; J Cox; W Meyer; A Courtney; T Hanson; C Green-Weaver; J Agosti
Comparison of neutrophil and monocyte function by microbicidal cell-kill assay in patients with cancer receiving granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, or no cytokine after cytotoxic chemotherapy: a phase II trial.
American journal of clinical oncology 1998;21(3):308-12.
1997: John Nemunaitis; J Cox; W Meyer; A Courtney; G Mues
Irinotecan hydrochloride (CPT-11) resistance identified by K-ras mutation in patients with progressive colon cancer after treatment with 5-fluorouracil (5-FU).
American journal of clinical oncology 1997;20(5):527-9.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.